|
1. Zhang WX. Nanoscale iron particles for environmental remediation: An overview. Journal of Nanoparticle Research. 2003; 5:323-32. doi:10.1023/A:1025520116015 2. Magaye RR, Yue X, Zou B, Shi H, Yu H, Liu K, et al. Acute toxicity of nickel nanoparticles in rats after intravenous injection. Int J Nanomedicine. 2014 Mar; 9: 1393-402. doi:10.2147/IJN.S56212 3. Vaidyanathan R, Kalishwaralal K, Gopalram S, Gurunathan S. Nanosilver--the burgeoning therapeutic molecule and its green synthesis. Biotechnol Adv. 2009 Nov-Dec; 27(6): 924-37. doi:10.1016/j.biotechadv.2009.08.001 4. Abdelhalim MA, Jarrar BM. Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration. J Nanobiotechnology. 2012 Jan; 10: 5. doi:10.1186/1477-3155-10-5 5. Jacob SE, Moennich JN, McKean BA, Zirwas MJ, Taylor JS. Nickel allergy in the United States: a public health issue in need of a "nickel directive". J Am Acad Dermatol. 2009 Jun; 60(6): 1067-9. doi: 10.1016/j.jaad.2008.11.893 6. Hillyer JF, Albrecht RM. Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J Pharm Sci. 2001 Dec; 90(12): 1927-36. 7. National Toxicology Program. NTP Toxicology and Carcinogenesis Studies of Nickel Oxide (CAS No. 1313-99-1) in F344 Rats and B6C3F1 Mice (Inhalation Studies). Natl Toxicol Program Tech Rep Ser. 1996 Jul; 451: 1-381. 8. Poland CA, Byrne F, Cho WS, Prina-Mello A, Murphy FA, Davies GL, et al. Length-dependent pathogenic effects of nickel nanowires in the lungs and the peritoneal cavity. Nanotoxicology. 2012 Dec; 6: 899-911. doi:10.3109/17435390.2011.626535 9. Bulte JW, Brooks RA, Moskowitz BM, Bryant LH Jr, Frank JA. Relaxometry and magnetometry of the MR contrast agent MION-46L. Magn Reson Med. 1999 Aug; 42(2): 379-84. 10. Yousefi Babadi V, Amraeai E, Salehh H, Sadeghi L, Najafi L, Fazilati M. Evaluation of Iron oxidenanoparticles effects on tissue and enzymes of thyroid in rats. Int Res J Biological Sci. 2013; 2(7): 67-69. 11. Bruce RJ, Djamali A, Shinki K, Michel SJ, Fine JP, Pozniak MA. Background fluctuation of kidney function versus contrast-induced nephrotoxicity. AJR Am J Roentgenol. 2009 Mar; 192(3): 711-8. 12. Rety F, Clement O, Siauve N, Cuenod CA, Carnot F, Sich M, et al. MR Lymphography using Iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection. J Magn Reason Imaging. 2000; 12(5): 734-39. 13. Doudi M, Setorki M. Effect of Nanoparticles Fe4NiO4Zn on Liver Enzymes-White Blood Cell and Hematocrit in Wistar Rat. Journal of Biological Sciences. 2014; 14(7): 480-84. doi:10.3923/jbs.2014.480.484 14. Iversen NK, Frische S, Thomsen K, Laustsen C, Pedersen M, Hansen PB, et al. Superparamagnetic iron oxide polyacrylic acid coated γ-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol Appl Pharmacol. 2013 Jan; 266(2): 276-88. doi:10.1016/j.taap.2012.10.014 15. Doudi M, Setorki M. [Effects of dioxide-Titanium nanoparticles on function and tissue of kidney]. Uremia Medical Journal. 2014; 25(8): 684-92. [Article in Persian] 16. Azadeh N, Hooshmandi Z, Setorki M. [Effect of Fe4NiO4Zn nanoparticles on serum urea-uric acid and creatinine in male rat]. Medical Journal of Tabriz University of Medical Sciences and Health Services. 2015; 37(3): 6-11. [Article in Persian]
|
